drugset
drugset / Trial / NCT04982913

Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects

NCT04982913 ↗

Phase 1 Completed 118 enrolled Sunshine Lake Pharma Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The Safety, Tolerability, Pharmacokinetic, Food Effect Study and the interaction with Oseltamivir Phosphate Capsules of HEC116094 in Healthy Subjects

Timeline

Start
2021-08-24
Primary completion
2022-10-02
Completion
2022-10-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Oseltamivir Small molecule — —

Indications

influenza